Respiratory syncytial virus (RSV) is increasingly recognized as a major pathogen in frail older adults and a cause of exacerbations of chronic obstructive pulmonary disease (COPD). Although there are studies examining the burden in hospitalized COPD cohorts, there has been no work evaluating the burden in the outpatient setting in this group.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Study on tinnitus in everyday practice
ENT specialists rely on Ginkgo biloba
- Hodgkin's lymphoma
No more transplants for relapsed or refractory HL in the future?
- Gram-negative foot infection
Not to be taken lightly
- Severe asthma
Anti-IL-5/-5Rα biologics impress in the real world
- Significance, diagnostics and treatment options for cardiology practice
Coronary artery spasm and atherosclerosis
- Smoldering multiple myeloma
Daratumumab delays progression in smoldering multiple myeloma
- Invitation to the 12th IBD Roadshow | June 23-25, 2025 | with Professor Bruce Sands
Acceleration in IBD Treatment: How early and holistic care leads to better outcomes
- Chronic hand eczema